• Checking All the Boxes

    by Jessica Santos  |  Sep 18, 2018
    Navigating through compliance issues and regulatory mazes when designing a patient study is undoubtedly difficult, but success can be more easily achieved through a well-conceived, high-quality approach.
  • GDPR: Protecting Patient Privacy in Europe

    by Jessica Santos  |  Aug 22, 2018
    Having taken effect in May 2018, the GDPR imposes new obligations on organizations that process the personal data of EU residents, including research agencies, pharmaceutical manufacturers and data analytic companies.
  • Eureka Moments!

    by Richard Goosey  |  Aug 17, 2018
    The revolutionary new uses of the “share of preference” measurement is a eureka moment in marketing science for the pharmaceutical industry. Combined with a brand’s existing market share, share of preference can now be used to look at where a brand’s market share currently stands, where it could rise to, and most importantly how to get there by pulling the lever and minimizing the impact of barriers!
  • Think You Know Brazil?

    by Otávio Clark  |  Aug 13, 2018
    Brazil is bursting with opportunities for pharma companies- but only those who understand this growth market's nuances will succeed.
  • Fine Margins

    by Mark Sales  |  Jul 20, 2018
    The day has come for us to use evidence to make our decisions, not only at launch but throughout the product lifecycle. We need to not simply rely on the classic "rear view metrics", but instead find the leading indicators and leverage modern marketing science to make the right decisions and achieve those collective fine margins.
More than one Google Analytics scripts are registered. Please verify your pages and templates.